News | January 18, 2012

Baptist Cardiac and Vascular Institute Aligns With Top European University to Access Latest Device Technology

The University of Heidelburg

The University of Heidelburg

January 18, 2012 — Baptist Cardiac & Vascular Institute of Miami announced a partnership with the University of Heidelberg, one of the largest and most important centers for patient care, medical research and teaching in Europe, for hands-on access to the latest medical innovations.

"Our institute has set the agenda in South Florida for cardiac and vascular procedures and treatment, but a lot of medical innovations are happening outside the United States. Our affiliation with the University of Heidelberg will bring a new line of knowledge in clinical medicine and broaden our perspective about new developments in patient care," Barry T. Katzen, M.D., founder and medical director of the institute, said.

The relationship will benefit South Florida patients, granting access to the most advanced treatments available for cardiac and vascular systems performed by heart surgeons, interventional radiologists and vascular surgeons.

"In our regulatory environment, it takes three to four years for innovations to be approved here. Our doctors, by traveling to Heidelberg, will already have been involved in early-stage technology. Over time it will have significant implications in patient care," Katzen said.

Dittmar Bockler, M.D., medical director and chairman of the department for vascular and endovascular surgery at Heidelberg University Hospital, agrees the partnership will result in better care for patients in the United States and Germany.

"Whenever there is transatlantic collaboration, the shared knowledge results in new developments and refinements," Dr. Bockler said. "Baptist Cardiac & Vascular Institute is a leader in multidisciplinary care and has pioneered many procedures that are of great interest to European physicians."

Both organizations are renowned as groundbreakers in cardiovascular care, involved in dozens of clinical trials and sophisticated diagnostic, treatment and rehabilitation services. They share a goal of searching for the least invasive treatments, particularly important for an aging population. Teams of interventional radiologists, clinical and interventional cardiologists, cardiothoracic surgeons, vascular surgeons, electrophysiologists, and neuroradiologists work together to provide a spectrum of care ranging from wellness to the most complex endovascular and open surgical procedures for heart and circulatory problems.

Baptist Cardiac & Vascular Institute, established in 1987, is part of Baptist Health South Florida, the largest faith-based, not-for-profit healthcare organization in the region.

For more information: www.baptistheart.net

Related Content

Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Recent Acquisitions Eroding Prices in Billion Dollar European Interventional Cardiology cath lab Market.
Feature | Cath Lab | May 07, 2018 | Simon Trinh and Jeffrey Wong
The European interventional cardiology market is currently valued at nearly $1.4 billion.
Videos | Cath Lab | May 07, 2018
Imran Ahmad, M.D., medical director of interventional cardiology, explains some of the new technologies his labs have
360 Photos | Cath Lab | April 20, 2018
A 360 degree view of the newest cath lab at Northwestern Medicine Central DuPage Hospital in Winfield, Ill., located
SCAI Announces Global Lecture Series for 2018 Scientific Sessions
News | Cath Lab | April 18, 2018
Many of the world’s leading interventional cardiologists and cardiovascular professionals will convene in San Diego,...
Overlay Init